Glycaemic control is associated with COVID-19 breakthrough infections
Patients' characteristics might also influence the efficacy of vaccines against COVID-19. We show that poor glycaemic control is associated with a decreased immune response to Pfizer vaccine and also with an increased incidence of breakthrough infections in patients with Type 2 Diabetes.